Page last updated: 2024-08-26

vinpocetine and chronic COVID syndrome

vinpocetine has been researched along with chronic COVID syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Butakova, JS; Parshin, MS; Samartsev, IN; Zhivolupov, SA1

Other Studies

1 other study(ies) available for vinpocetine and chronic COVID syndrome

ArticleYear
[The open observational study of aceclofenac and vinpocetine effectiveness and tolerability in treatment of patients with chronic cerebrovascular disease after COVID-19 (AQUA study)].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2021, Volume: 121, Issue:11

    Topics: Aged; Cerebrovascular Disorders; COVID-19; COVID-19 Drug Treatment; Diclofenac; Female; Humans; Male; Middle Aged; Post-Acute COVID-19 Syndrome; Vinca Alkaloids

2021